Acceder

Cotización de Vera Therapeutics, Inc (VERA) hoy en tiempo real

Vera Therapeutics, Inc (VERA)

Análisis técnico y gráfico histórico de Vera Therapeutics, Inc

Análisis fundamental y estadísticas clave de Vera Therapeutics, Inc

Ficha de Vera Therapeutics, Inc (VERA)

Ticker VERA
ISIN US92337R1014
Sector Tecnología
Mercado NASDAQ

Análisis financiero de Vera Therapeutics, Inc

Briefing Valoración Rentabilidad Métricas por acción Deuda Liquidez

Resumen financiero e información corporativa de Vera Therapeutics, Inc

Invertir en Vera Therapeutics, Inc en 2026: Preguntas frecuentes

¿Qué es Vera Therapeutics, Inc?

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clin...

¿En qué sector opera Vera Therapeutics, Inc?

Vera Therapeutics, Inc opera en el sector Healthcare, industria Biotechnology.